When UK-based GSK sold its drink business in 2013 to Japanese firm, Suntory Beverage & Food, to focus on its healthcare business, GSK’s Nigerian unit had not had the final straw of the iconic Ribena and Lucozade drinks.
Only the year before, annual sales of Ribena and Lucozade were around h
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```